PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Jan-2026 Frédéric Prince to Succeed Christian Loss, Effective January 1st, 2026 Businesswire
01-Jan-2026 AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com Businesswire
01-Jan-2026 Europe Image-Guided Drug Delivery Research Report 2025-2035: $284.1 Million Market Driven by Rising Chronic Disease Burden, Imaging Advancements, and Aging Populations - ResearchAndMarkets.com Businesswire
01-Jan-2026 Cell & Gene Therapies in Respiratory Disorders Therapeutic Analysis Report 2025: Landscape is Currently in the Early Stages of Development, with No Marketed CGTs to Date. - ResearchAndMarkets.com Businesswire
01-Jan-2026 Insomnia Market Opportunity Assessment and Forecast Report 2022-2032: Z-Drugs Remain First-Line as Sparse Pipeline Adds $288 Million From Late-Stage Entrants - ResearchAndMarkets.com Businesswire
01-Jan-2026 ARE Stockholders with Large Losses Should Contact Robbins LLP to Learn How to Lead the Alexandria Real Estate Equities, Inc. Securities Class Action Businesswire
30-Dec-2025 Dual Chamber Prefilled Syringes Market to Nearly Double by 2032 Reaching a Market Size of USD 323.7 Million at 8.1% CAGR Acumen Research And Consulting
28-Dec-2025 Dental Services Market Analysis 2025–2035: Growth Drivers, Trends, and Global Insights Acumen Research And Consulting
22-Dec-2025 Argentina Cement Industry Report 2025: Policy Volatility, Demand Cycles, and Sustainability Push Drive Strategic Realignment - Forecast to 2029 - ResearchAndMarkets.com Businesswire
22-Dec-2025 Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast Businesswire
22-Dec-2025 Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan iPark Businesswire
22-Dec-2025 InSilicoTrials With The Jackson Laboratory Lead CARDIOVERSE, a $30M Initiative Funded by ARPA-H to Redefine Cardiac Drug Safety with Virtual Heart Models Businesswire
22-Dec-2025 Shape Memory Medical Secures EU MDR Certification for IMPEDE® Embolization Plug Product Family, Accelerating Global Innovation in Vascular Care Businesswire
22-Dec-2025 Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA Businesswire
22-Dec-2025 Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes Businesswire
22-Dec-2025 KalVista Pharmaceuticals Announces Approval of EKTERLY® (sebetralstat) in Japan, First and Only Oral On-demand Treatment for Hereditary Angioedema Businesswire
22-Dec-2025 £25m fund for Glasgow’s health and life sciences innovators ‘is unmissable amid booming sector’ InnoScot Health
22-Dec-2025 Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease Businesswire
22-Dec-2025 Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma Businesswire
22-Dec-2025 Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer Businesswire